CORC

在结果中检索

CORC

浏览/检索结果: 共563条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Optimization of the epitaxial structure of low-loss 885nm high-power laser diodes 会议论文
Shanghai, China, 2021-06-03
作者:  Wu, Shun-Hua;  Li, Te;  Wang, Dan;  Yu, Xue-Cheng;  Wang, Zhen-Fu
收藏  |  浏览/下载：67/0  |  提交时间：2022/01/21
OSLNet: Deep Small-Sample Classification with an Orthogonal Softmax Layer 会议论文
作者:  Li, Xiaoxu;  Chang, Dongliang;  Ma, Zhanyu;  Tan, Zheng-Hua;  Xue, Jing-Hao
收藏  |  浏览/下载：2/0  |  提交时间：2020/12/18
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：140/0  |  提交时间：2019/12/02
Design and Performance Analysis of a Lateral Thrust Measuring Device 会议论文
2019 3rd International Conference on Artificial Intelligence, Automation and Control Technologies, AIACT 2019, Xi'an, China, 2019-04-25
作者:  Ren, Zongjin;  Hua, Mei;  Zhang, Jun;  Li, Yang
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Construction and functional analysis of luciferase reporter plasmid containing CAAP1 gene promoter 会议论文
作者:  Zhang, Hui-Min;  Wang, Jun;  Liao, Xing-Hua
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace